Fishman Pulmonary

[Hayley Sweigard]

CharlesL. Fishman, MD, FACP, FCCP, is a pulmonologist at NewYork-Presbyterian Medical Group Westchester and an assistant professor of medicine at Columbia University Medical Center. He has more than 25 years experience in pulmonary and critical care medicine, with a focus on lung cancer and airways disease. Dr. Fishman is board certified in pulmonary disease medicine and internal medicine, and a fellow of the American College of Physicians, the American College of Chest Physicians, and a member of the American Thoracic Society and the Bronx County Medical Society. He has contributed to research in the field of pulmonology for publications, including Proccedings, American Society of Clinical Oncology and Annals of Oncology. Dr. Fishman graduated from Mount Sinai School of Medicine. He completed his internship and residency in internal medicine at Montefiore Medical Center, where he was named chief resident in his final year. He went on to complete a fellowship in pulmonology and critical care medicine at New York University Medical Center. Prior to joining NewYork-Presbyterian, Dr. Fishman was an attending pulmonologist at Montefiore Medical Center and served as co-director of pulmonary consult service at the Wakefield campus.

Although this textbook is very expense (like its competitors), it provides considerable value as an educational tool. While on our pulmonary consult service, I did not find that it had sufficient depth to answer complex clinical questions. However, it was an outstanding place for me to relearn in subject areas where my current knowledge was weak. It is also an excellent site to send fellows and residents to read on a subject. The radiologic and some of the basic sections are outstanding syntheses of information that is difficult to learn efficiently from other sources. In spite of the expense, this is an excellent book for a pulmonary fellow or faculty member, particularly if it is used to fill holes in knowledge by reading relevant full chapters. A key question to be answered is how the online access and updating will occur, as this is essential to maintaining the relevance of the material.

N2 - Although this textbook is very expense (like its competitors), it provides considerable value as an educational tool. While on our pulmonary consult service, I did not find that it had sufficient depth to answer complex clinical questions. However, it was an outstanding place for me to relearn in subject areas where my current knowledge was weak. It is also an excellent site to send fellows and residents to read on a subject. The radiologic and some of the basic sections are outstanding syntheses of information that is difficult to learn efficiently from other sources. In spite of the expense, this is an excellent book for a pulmonary fellow or faculty member, particularly if it is used to fill holes in knowledge by reading relevant full chapters. A key question to be answered is how the online access and updating will occur, as this is essential to maintaining the relevance of the material.

AB - Although this textbook is very expense (like its competitors), it provides considerable value as an educational tool. While on our pulmonary consult service, I did not find that it had sufficient depth to answer complex clinical questions. However, it was an outstanding place for me to relearn in subject areas where my current knowledge was weak. It is also an excellent site to send fellows and residents to read on a subject. The radiologic and some of the basic sections are outstanding syntheses of information that is difficult to learn efficiently from other sources. In spite of the expense, this is an excellent book for a pulmonary fellow or faculty member, particularly if it is used to fill holes in knowledge by reading relevant full chapters. A key question to be answered is how the online access and updating will occur, as this is essential to maintaining the relevance of the material.

All content on this site: Copyright 2024 Elsevier B.V. or its licensors and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the Creative Commons licensing terms apply

First published in 1980, Fishman's Pulmonary Diseases & Disorders is the classic reference through which pulmonary physicians have gained a commanding look at the diagnosis and treatment of pulmonary diseases and disorders. Edited by the world's foremost authorities, Fishman's Pulmonary Diseases & Disorders covers exactly what you need to know about lung diseases and their management, including sleep-disordered breathing, COPD, emphysema, and lung cancer, as well as new technological advances and imaging techniques.

This unparalleled two-volume resource begins with a compelling overview of up-to-date clinical perspectives, along with the scientific basis of lung function health and disease. It then provides turnkey information on everything from respiratory disease signs and symptoms, to obstructive lung diseases, occupational and environmental disorders, and specific respiratory conditions such as infections diseases of the lungs and acute respiratory failure.

The site is secure.

The ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

The CT scans of 18 patients with documented pulmonary septic emboli were reviewed. CT features of septic emboli included multiple peripheral nodules ranging in size from 0.5 to 3.5 cm (15 of 18 patients [83%]), a feeding vessel sign (n = 12; [67%]), cavitation (n = 9; [50%]), wedge-shaped peripheral lesions abutting the pleura (n = 9 [50%]), air bronchograms within nodules (n = 5 [28%]), and extension into the pleural space (n = 7 [39%]). In six of the 18 patients, CT was the first modality (before radiography) to show lesions compatible with septic emboli. In five clinically unsuspected cases, CT first suggested the correct diagnosis of septic emboli. In eight patients, CT also enabled identification of more parenchymal lesions, presumed to be septic emboli, and more pleural involvement than chest radiographs, thus demonstrating a greater extent of disease. The authors conclude that CT is an important modality for confirming the presence of pulmonary septic emboli even when conventional chest radiographs remain negative. In the proper clinical setting, characteristic CT features of septic emboli can suggest the correct diagnosis.

We use cookies and similar tools that are necessary to enable you to make purchases, to enhance your shopping experiences and to provide our services, as detailed in our Cookie notice. We also use these cookies to understand how customers use our services (for example, by measuring site visits) so we can make improvements.

If you agree, we'll also use cookies to complement your shopping experience across the Amazon stores as described in our Cookie notice. Your choice applies to using first-party and third-party advertising cookies on this service. Cookies store or access standard device information such as a unique identifier. The 103 third parties who use cookies on this service do so for their purposes of displaying and measuring personalized ads, generating audience insights, and developing and improving products. Click "Decline" to reject, or "Customise" to make more detailed advertising choices, or learn more. You can change your choices at any time by visiting Cookie preferences, as described in the Cookie notice. To learn more about how and for what purposes Amazon uses personal information (such as Amazon Store order history), please visit our Privacy notice.

Since 1980, Fishman's Pulmonary Diseases and Disorders has delivered unparalleled coverage of pulmonary medicine and the underlying basic and applied science upon which clinical practice is based. The Fifth Edition, with 270 contributing authors, includes over 2,000 illustrations, 60 videos, and 18,000 references. The book opens with a comprehensive overview of the scientific basis of lung function in health and disease. It then provides detailed coverage of the broad array of diseases and disorders affecting the respiratory system, including obstructive and restrictive diseases, pulmonary vascular disorders, sleep-disordered breathing, lung neoplasms,respiratory infections, and respiratory failure, among others.

A $3 million gift from University of Pennsylvania alumnus Jay Fishman, and his wife, Randy, will support comprehensive at-home respiratory care for adult Penn Medicine patients with chronic respiratory insufficiency due to neurological, muscular, skeletal or chronic respiratory diseases, including amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.

Penn Medicine is partnering with The ALS Association to have the program recognized as an ALS Association-approved program in pulmonary care. Such a designation would be a first for a specific medical practice within the broad ALS clinical arena. The intent of the program is to deliver the benefits of rapidly emerging new technologies and related data to physicians caring for patients whose breathing is compromised.

Working in close collaboration with neurologists who staff the Penn Comprehensive ALS Center and the Penn Muscular Dystrophy Association Clinic, the physicians who lead the Home Assisted Ventilation Program will coordinate the efforts of a wide array of multidisciplinary specialists, including respiratory therapy, speech therapy, gastrointestinal medicine and surgery, nutrition, physical therapy and rehabilitation medicine. The Fishman Program will also focus on medical education, providing a one-year advanced fellowship training program in the care of adults who need home-assisted ventilation.

Mr. Fishman, executive chairman of the board and former chief executive officer of The Travelers Companies, Inc. and a member of the University of Pennsylvania Board of Trustees, was diagnosed with ALS in 2014. [Ed. Note: He passed away on August 19; see here.]

3a8082e126